EAM
BNTC icon

Evanson Asset Management’s Benitec Biopharma BNTC Stock Holding History

Evanson Asset Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-86
Closed -$2K – 203
2016
Q1 		$2K Buy
+86
New +$63.2K ﹤0.01% 199

Other funds holding BNTC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Evanson Asset Management's BNTC Position: Q2 2016 in Review

Evanson Asset Management sold out of Benitec Biopharma (BNTC) in Q2 2016, closing a stake of 86 shares — an estimated $2K sold.

Evanson Asset Management first reported a position in BNTC in Q1 2016 and held it in 1 quarter. The position peaked at $2K in Q1 2016. 3 funds tracked by Wall St. Rank hold BNTC as of Q2 2016.

  • Evanson Asset Management reported no remaining Benitec Biopharma position as of Q2 2016 after selling out during the quarter.
  • Evanson Asset Management sold 86 Benitec Biopharma shares in Q2 2016, an estimated $2K.
  • Evanson Asset Management first reported a position in Benitec Biopharma in Q1 2016 and held it in 1 quarter.
  • Evanson Asset Management's Benitec Biopharma position peaked at $2K in Q1 2016.
  • 3 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2016.

Based on Evanson Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.